NCT04888572 (IDRA) is a clinical trial of Peri-Apical X-ray in Peri-Implantitis, sponsored by Saint-Joseph University.

Who is sponsoring NCT04888572?

NCT04888572 is sponsored by Saint-Joseph University.

What drugs are being tested in NCT04888572?

Interventions in NCT04888572: Peri-Apical X-ray.

What condition does NCT04888572 study?

NCT04888572 studies Peri-Implantitis, Implant Expulsion.

Is NCT04888572 still recruiting?

NCT04888572 is currently status unknown. Last updated 26 October 2022.

Last reviewed 2022-10-26 · How we verify

NCT04888572: IDRA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Novel Implant Disease Risk Assessment : a Retrospective Study (IDRA)

Status unknown Last updated 26 October 2022

What this trial tests

trial testing Peri-Apical X-ray in Peri-Implantitis in 500 participants. Status unknown.

Timeline

11 May 2021

Primary endpoint
20 December 2022

20 December 2022

Quick facts

Lead sponsor	Saint-Joseph University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	11 May 2021
Primary completion	20 December 2022
Estimated completion	20 December 2022
Sites	1 location across Lebanon

Drugs / interventions tested

Peri-Apical X-ray

Conditions studied

Peri-Implantitis — all drugs for Peri-Implantitis →
Implant Expulsion — all drugs for Implant Expulsion →

Sponsor

Saint-Joseph University

Who can join

18 and older, any sex, with Peri-Implantitis or Implant Expulsion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Given the novelty of this risk assessment tool, this study will be interested in evaluating its effectiveness through a retrospective approach. The IDRA risk will be analyzed at the time of loading the implant (s) in patients who have already placed an implant (s) during the last five years at the Department of Periodontology and Oral Surgery using the information collected from the periodontal file previously completed. Therefore, patients whose IDRA has been calculated will be called for a clinical and radiological examination to verify the development or not of peri-implantitis or the loss of the implant. In this way, this tool for predicting peri-implant disease will be evaluated to see if it is really effective.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Assessment of the association between the Implant Disease Risk Assessment (IDRA) tool and peri-implantitis: a retrospective cohort study with up to 8 years of follow-up.
Rebeiz T, Nasr L, Kassir AR, Menassa G, et al · · 2024 · cited 2× · PMID 38806315 · DOI 10.1016/j.ijom.2024.05.002

Verify or expand the search:

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

NCT07012915 — Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis · NA · recruiting
NCT06679283 — Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) · NA · recruiting
NCT06017817 — Antibacterial Photodynamic Therapy in the Management of Peri-implantitis · NA · recruiting
NCT06364982 — Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease. · recruiting
NCT06288919 — Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials · NA · active not recruiting

Other Saint-Joseph University trials

Trials by the same sponsor.

NCT07449884 — AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia · NA · recruiting
NCT07350746 — A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a · NA · active not recruiting
NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
NCT07525128 — Lateral GBR Using Two Types of Membrane With a Combination of Allograft-xenograft · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04888572 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint-Joseph University
Last refreshed: 26 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04888572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing